Sentences with phrase «$ ibb»

Review this recent post on our trading blog to see the bearish setup for $ IBB.

About five years ago, iShares NASDAQ Biotechnology ETF ($ IBB) kicked off a massive uptrend that lasted 3 1/2 years and led to a 400 % gain.

That same moving average crossover happened in $ IBB last September as well, BUT the 10 - week MA fell back below the 40 - week MA (until two weeks ago).

If you profited from this $ IBB trade with our entry and exit signals, or perhaps managed the trade in a different way, feel free to leave us a comment below.

The daily chart pattern below details our exact entries and exit prices for the $ IBB swing trade.

iShares NASDAQ Biotechnology ETF ($ IBB) About five years ago, iShares NASDAQ Biotechnology ETF ($ IBB) kicked off a -LSB-...]

On September 6, via Courtesy Trade Confirmation alert to subscribers, we confirmed the exit of our $ IBB position when it hit the official target price of $ 140.80.

These bullish signs indicate that $ IBB may soon reward astute traders with a breakout that carries it 13 - 15 % higher from here (next resistance is ~ $ 340).

$ IBB) is this type of setup.

We scratched on one position ($ AMLN), and locked in small gains on the other two long positions ($ IBB and $ LF).

Based on the weekly and daily chart patterns above, we have officially added $ IBB to our watchlist as a potential swing trade setup on the short side.

This is shown on the weekly chart of $ IBB below:

Notice how the recent highs of $ IBB over the past few days correspond to the highs of the «left shoulder.»

Our short setup in iShares Nasdaq Biotechnology Index ($ IBB) remains on our watchlist as a candidate for potential swing trade short sale entry going into today (December 17).

After showing market leadership throughout 2011 and much of 2012, iShares NASDAQ Biotechnology Index ($ IBB) has spent the past few months digesting gains and building a new base above long - term support of its 200 - day moving average.

Although money rotated out of $ IBB in the fourth quarter of 2012, the price action has recovered nicely.

With a bit of help from the broad market, $ IBB could soon see a volatility expansion and breakout above the highs of the range (above the $ 148 level).

Regular subscribers of The Wagner Daily should note our clear, predefined trigger, stop, and target prices for the $ QQQ and $ IBB trade setups in the ETF Trading Watchlist section of today's report.

The rectangular area on the chart above is our ideal «buy zone» for $ IBB ($ 149 to $ 150 range).

First, let's take a look at the longer - term weekly chart, which shows that $ IBB just broke out above a valid base of consolidation last week:

One ETF on our radar screen for potential pullback buy entry is iShares Nasdaq Biotech Index ($ IBB).

At the opening bell of last Friday's session, we sold our position in iShares Nasdaq Biotech ($ IBB) for a modest gain.

The biggest gainer was iShares Nasdaq Biotechnology ETF ($ IBB), which broke out above its recent consolidation and cruised 1.5 % higher.

In today's stock pick video, we discuss the potential swing trade setups in 2 stocks and 2 ETFs: $ SPY, $ IBB, $ TPX, and $ MW.

Because biotech has been one of the strongest industry sectors for many months of the current bull run, it will be important to see how $ IBB reacts in the coming weeks.

More concerning is that $ IBB sliced through its 50 - day moving average with ease, as volume surged higher as well:

One such ETF to put on your watchlist is iShares Nasdaq Biotech Index ($ IBB).

Not exact matches

The iShares Nasdaq Biotechnology ETF (IBB) hit a high of $ 300.29 Thursday, and closed at $ 300.08, just below the $ 302.40 level hit in January.

Ultimately, Ross believes that when the breakout above $ 300 does occur, the IBB could rally as high as $ 325 — or another 10 percent from current levels.

Last Thursday, September 6, we sold IBB for a 7 - point gain when it hit our original price target of $ 140.80.

Which likely means we can continue to see the IBB just continue to trade in place, in the $ 285 to $ 305 range.

From February of 2016 through June of 2017 IBB traded in a tight range from $ 83 to $ 98 while Donald Trump continually fired shots against the healthcare sector.

The sustained sell - off lead to the entire cohort to sell off from all - time highs of $ 132 to $ 83 or 37 % in only 6 months as measured via the iShares Nasdaq Biotechnology ETF (IBB).

To start there is an indie title called ibb and obb which usually runs $ 9.99.

Castle Crashers (PS3) $ 3.49 ($ 14.99) Cloudberry Kingdom (PS3) $ 2.49 ($ 9.99) Divekick (PS Vita, Cross-Buy) $ 2.49 ($ 9.99) Divekick (PS3, Cross-Buy) $ 2.49 ($ 9.99) Fat Princess (PS3) $ 3.49 ($ 14.99) House of the Dead Overkill: Extended Cut (PS3) $ 4.99 ($ 19.99) ibb & obb (PS3) $ 4.99 ($ 9.99) Kane & Lynch 2: Dog Days (PS3) $ 4.99 ($ 19.99) Kane & Lynch: Dead Men (PS3) $ 3.99 ($ 14.99) LEGO Marvel Super Heroes (PS Vita) $ 19.99 ($ 29.99) LEGO Marvel Super Heroes (PS3) $ 24.99 ($ 49.99) LEGO Marvel Super Heroes (PS4) $ 29.99 ($ 59.99) NBA 2K14 (PS3) $ 39.99 ($ 59.99) NBA 2K14 BLUE DIAMOND JEWELRY COLLECTION (PS3) $ 12.49 ($ 24.99) NBA 2K14 GOLD JEWELRY COLLECTION (PS3) $ 2.49 ($ 4.99) NBA 2K14 PLATINUM JEWELRY COLLECTION (PS3) $ 4.99 ($ 9.99) PlayStation All - Stars Battle Royale (PS3) $ 9.99 ($ 39.99) Renegade Ops (PS3) $ 2.49 ($ 9.99) Scott Pilgrim (PS3) $ 2.49 ($ 9.99) Toy Story Mania (PS3) $ 9.99 ($ 39.99)